Radiotherapy and Oncology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
211: Outcomes of Radiotherapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCIS).
150:S89-S90.
2020
-
62: A Prospective Provincial Psma-Pet Registry for Recurrent Prostate Cancer: Preliminary Results.
150:S30-S30.
2020
-
International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
142:180-185.
2020
-
189 Bone Scans in the Management of Metastatic Castrate-Resistant Prostate Cancer: Survey of Patterns of Practice in Canadian Radiation Oncologists, Medical Oncologists and Urologists.
139:S79-S80.
2019
-
2 Drive: Defining Radiorecurrent Intraprostatic Target Volumes.
139:S4-S4.
2019
-
70 Quantifying Tumour Dose Using Individualized Dosimetry Methodology in 177LU Dotatate Therapy.
139:S32-S32.
2019
-
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
135:19-24.
2019
-
Single versus multifraction radiotherapy for spinal cord compression: A systematic review and meta-analysis.
134:55-66.
2019
-
MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML).
129:540-547.
2018
-
Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.
126:541-546.
2018
-
Radiation therapy quality indicators for invasive breast cancer.
123:288-293.
2017
-
Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial.
121:414-419.
2016
-
146: Current Practice of External Beam Radiotherapy and Brachytherapy for Management of Endometrial Cancer in Ontario, Canada.
120:S54-S54.
2016
-
33: Brachytherapy as a Sole Treatment Modality for Early Esophageal Cancer (EEC).
120:S12-S13.
2016
-
Metformin for chemo-radio-sensitization of NSCLC.
120:363-364.
2016
-
A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
119:208-212.
2016
-
Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.
118:547-551.
2016
-
A dosimetric study of cardiac dose sparing using the reverse semi-decubitus technique for left breast and internal mammary chain irradiation.
118:187-193.
2016
-
Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U).
115:141-148.
2015
-
The prostate cancer risk stratification (ProCaRS) project: Recursive partitioning risk stratification analysis.
109:204-210.
2013
-
External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy.
105:94-100.
2012
-
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors.
105:101-106.
2012
-
Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells.
102:459-465.
2012
-
Total quality culture in radiotherapy departments across Ontario.
99:90-93.
2011
-
Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency.
97:488-494.
2010
-
Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: A systematic review and meta-analysis.
88:1-9.
2008
-
59 Radiation — Induced apoptosis of lymphocytes to predict normal tissue late toxicity from radiotherapy.
76:S18-S18.
2005
-
93 Radiation-induced apoptosis of lymphocytes to predict late toxicity from radiotherapy.
72:S29-S29.
2004
-
Accuracy of ultrasound in localization of breast boost field.
72:61-66.
2004
-
Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency.
64:297-308.
2002
-
The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer – a systematic review.
64:239-250.
2002
-
Erratum.
50:371-371.
1999
-
Oxygenation predicts radiation response and survival in patients with cervix cancer.
48:149-156.
1998
-
Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography.
47:277-284.
1998
-
Accelerated radiation therapy for primary lymphoma of the brain.
47:191-195.
1998
-
Patient preference for high or low dose rate brachytherapy in carcinoma of the cervix.
33:187-194.
1994
-
A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL
2020
-
CARDIAC MORBIDITY FOLLOWING RADICAL THORACIC CHEMORADIOTHERAPY FOR LOCALLY ADVANCED LUNG CANCER: A POPULATION-BASED COHORT STUDY
2020
-
ENABLING ACCESS TO CERVCIAL CANCER RADIOTHERAPY IN UGANDA: 10 YEAR UPDATE ON ROAD TO CARE
2020
-
SURGERY VERSUS SBRT FOR EARLY-STAGE NSCLC IN OCTOGENARIANS AND NONAGENARIANS: AN OVERALL SURVIVAL DIFFERENCE?
2020
-
CANAGLIFLOZIN, A NEW ANTI-DIABETIC AGENT TARGETING CELLULAR METABOLISM, SUPPRESSES SURVIVAL AND ENHANCES THE RESPONSE OF NON-SMALL CELL LUNG CANCER (NSCLC) TO RADIOTHERAPY
2019
-
CYBERKNIFE STEREOTACTIC RADIOSURGERY FOR TREATMENT OF BENIGN INTRACRANIAL MENINGIOMA: LONG-TERM SAFETY AND EFFICACY
2019
-
IMPACT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY (IMRT) ON LYMPH NODE COVERAGE AND DOSE TO CRITICAL ORGANS, COMPARE TO THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT), IN LOCALIZED HIGH-RISK PROSTATE CANCER
2019
-
QUANTIFYING TUMOUR DOSE USING INDIVIDUALIZED DOSIMETRY METHODOLOGY IN 177LU DOTATATE THERAPY
2019
-
THE IMPACT OF ROUTINE ESAS USE ON EMERGENCY DEPARTMENT VISITS AND HOSPITALIZATIONS: A POPULATION-BASED RETROSPECTIVE MATCHED COHORT STUDY
2019
-
THE NEW DIABETES DRUG CANAGLIFLOZIN ENHANCES THE RESPONSE OF PROSTATE CANCER TO RADIOTHERAPY
2019
-
PV-0473: Dosimetry, safety, efficacy and QoL in a study of 5-fraction SBRT for oligometastatic (OM) cancers
2018
-
EP-1387: Time Trends In Opioid Use In Cancer Patients with Pain: Observations from Administrative Data
2017
-
PO-0971: Production of Gd-153 as a source isotope for use in rotating shield high dose rate brachytherapy
2016
-
1284 poster AUTOMATED 2D/3D REGISTRATION FOR LUNG BRACHYTHERAPY
2011
-
536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY
2011
-
A PROSPECTIVE STUDY OF FDG-PET IMAGING IN ASSESSMENT OF RESPONSE TO THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA UNDERGOING SALVAGE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT
2010
-
AN EDUCATIONAL PROGRAM IN ONCOLOGY FOR FAMILY MEDICINE TRAINEES
2010
-
ASSESSING CONFORMITY BETWEEN THE CLINICAL SPECIALIST RADIATION THERAPIST (CSRT) AND RADIATION ONCOLOGISTS FOR TARGET VOLUME DELINEATION AND FIELD PLACEMENT IN PALLIATIVE PATIENTS
2010
-
DOES 3D VERSUS 2D PLANNING TECHNIQUES MAKE A DIFFERENCE IN PALLIATIVE RADIOTHERAPY?
2010
-
EVALUATING THE FEASIBILITY OF TELEMEDICINE FOR NEW PATIENT CONSULTATIONS IN PALLIATIVE RADIOTHERAPY
2010
-
FEASIBILITY OF BONE MARROW SPARING USING INTENSITY MODULATED RADIOTHERAPY IN A PATIENT WITH INTERMEDIATE RISK PROSTATE CANCER AND COMPROMISED PLATELET COUNT DUE TO CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA.
2010
-
INTENSITY-MODULATED RADIOTHERAPY (IMRT) AND CONCURRENT CHEMOTHERAPY FOR ANAL AND PERIANAL CANCER: THE PRINCESS MARGARET HOSPITAL EXPERIENCE
2010
-
ONLINE PLANNING AND DELIVERY TECHNIQUE FOR PALLIATIVE RADIOTHERAPY OF BONE METASTASES
2010
-
SYMPTOM BURDEN AND PERFORMANCE STATUS IN A POPULATION BASED COHORT OF CANCER PATIENTS
2010
-
THREE-YEAR OUTCOMES OF A CANADIAN MULTI-CENTRE STUDY OF ACCELERATED PARTIAL BREAST IRRADIATION (APBI) USING CONFORMAL RADIATION THERAP
2010
-
110 ACTIVATORS OF AMP-ACTIVATED PROTEIN KINASE (AMPK) ENHANCE RADIATION RESPONSES IN LUNG CANCER CELLS
2009
-
126 FACTORS INFLUENCING DOSE/FRACTIONATION CHOICES FOR PALLIATION OF BONE METASTASES
2009
-
136 DOSIMETRIC COMPARISON OF DIFFERENT DOSE PRESCRIPTIONS AND BEAM WEIGHTINGS FOR VOLUMETRIC TREATMENT PLANS FOR VERTEBRAL METASTASES
2009
-
154 HEALTH SYSTEM CHARACTERISTICS ASSOCIATED WITH PATTERNS OF PALLITIVE CARE USE IN ONTARIO
2009
-
17 DETERMINING PATTERNS OF THERAPY CHOICE IN PATIENTS TREATED FOR EARLY STAGE, AGGRESSIVE HISTOLOGY NONHODGKIN'S LYMPHOMA
2009
-
182 INTENSITY MODULATED RADIOTHERAPY (IMRT) AND CONCURRENT CHEMOTHERAPY (CHT) FOR ANAL AND PERIANAL CANCER: PRELIMINARY REPORT OF ACUTE TOXICITY
2009
-
193 PHOTODYNAMIC THERAPY AS A TREATMENT OPTION FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE LOWER EXTREMITY
2009
-
30 PET START: THE FIRST RANDOMIZED CLINICAL TRIAL EVALUATING THE IMPACT OF POSITRON EMISSION TOMOGRAPHY IN STAGE III NON-SMALL CELL LUNG CANCER
2009
-
44 COPY NUMBER ALTERATION PREDICTS FOR BIOCHEMICAL RECURRENCE IN LOCALIZED PROSTATE CANCER USING HIGHRESOLUTION ARRAY COMPARATIVE GENOMIC HYBRIDIZATION
2009
-
46 IONIZING RADIATION ACTIVATES AMP – ACTIVATED PROTEIN KINASE (AMPK) IN HUMAN EPITHELIAL TUMOUR CELLS THROUGH AN LKB1-INDEPENDENT AND ATM-DEPENDENT PATHWAY
2009
-
52 IMPLEMENTATION OF A SEMI-AUTOMATIC VERTEBRA DETECTION AND SEGMENTATION ALGORITHM FOR RADIOTHERAPY OF SPINOUS BONE METASTASES
2009
-
63 DYSPAREUNIA AFTER CHEMORADIATION (CHEMO-RT) FOR ANAL CARCINOMA -AN UNDER REPORTED COMPLICATION
2009
-
99 DEVELOPMENT OF A CANADIAN PALLIATIVE RADIATION ONCOLOGY CURRICULUM
2009
-
A CANADIAN MULTI-CENTRED ASSESSMENT OF CANCER PAIN MANAGEMENT USING THE PAIN MANAGEMENT INDEX
2009
-
FUNGAL INFECTION IS A SIGNIFICANT CAUSE OF ODYNOPHAGIA IN ESOPHAGEAL CANCER PATIENTS AFTER BRACHYTHERAPY
2009
-
A POPULATION - BASED STUDY OF THE FRACTIONATION OF POST - LUMPECTOMY BREAST RADIOTHERAPY IN ONTARIO
2008
-
A POPULATION-BASED STUDY OF THE FRACTIONATION OF POST-LUMPECTOMY BREAST RADIOTHERAPY IN ONTARIO
2008
-
A PROSPECTIVE EVALUATION OF QUALITY OF LIFE IN PATIENTS WITH GASTRIC ADENOCARCINOMA IN A PHASE I STUDY OF ADJUVANT CHEMORADIATION
2008
-
A RETROSPECTIVE REVIEW OF THE INCIDENCE OF BRAIN METASTASES IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
2008
-
ACUTE URINARY MORBIDITY OF RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: DO PATIENTS UNDERGOING CONFORMAL RADIATION THERAPY WITH IMPLANTED GOLD SEEDS HAVE MORE URINARY SYMPTOMS DURING RADIATION THERAPY?
2008
-
ADJUVANT EXTERNAL BEAM RADIOTHERAPY IN THE TREATMENT OF ENDOMETRIAL CANCER: RESULTS OF THE RANDOMIZED MRC ASTEC AND NCIC EN.5 TRIALS, A SYSTEMATIC REVIEW AND META-ANALYSIS
2008
-
CONSTRUCTION AND TESTING OF A SYMPTOM CHECK-LIST FOR PATIENTS WITH BRAIN METASTASES
2008
-
DELIVERY OF LESS THAN INTENDED CISPLATIN (COOP) DOSE INTENSITY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC) RECEIVING CONCURRENT CHEMORADIATION (CRT) CORRELATES WITH POORER OUTCOME
2008
-
DOSIMETRIC EVALUATION OF STABILIZING NEEDLES AND SEMINAL VESICLE IMPLANTS FOR LDR PROSTATE BRACHYTHERAPY
2008
-
IMPACT OF BLADDER FILLING (FULL OR EMPTY) ON DOSE VOLUME HISTOGRAMS IN RADIATION PLANNING FOR POST-PROSTATECTOMY PATIENTS
2008
-
INFLUENCE OF GOLD SEED IMPLANTATION ON DEFINING TARGET VOLUMES FOR CONFORMAL RADIOTHERAPY OF PROSTATE CANCER
2008
-
INTEGRATING FAMILY PHYSICIANS INTO CANCER CARE
2008
-
INVESTIGATING RESVERATROL IN COMBINATION WITH RADIATION IN PROSTATE CANCER
2008
-
LONG-TERM RESULTS OF A RANDOMIZED TRIAL OF ACCELERATED HYPOFRACTIONATED WHOLE BREAST IRRADIATION FOLLOWING BREAST CONSERVING SURGERY IN WOMEN WITH NODE-NEGATIVE BREAST CANCER
2008
-
LOVASTATIN SENSITIZES NON-SMALL CELL LUNG CANCER (NSCLC) CELLS TO RADIATION; POSSIBLE INVOLVEMENT OF THE AKT SIGNALING PATHWAY
2008
-
MALIGNANT SPINAL CORD COMPRESSION: IDENTIFYING PATIENTS SUITABLE FOR SURGERY
2008
-
PALLIATIVE RADIOTHERAPY - HOW TO COPE WITH MULTIPLE PREVIOUS TREATMENT VOLUMES IN THE ELECTRONIC AGE
2008
-
PRELIMINARY RESULTS OF A PHASE II STUDY OF SINGLE FRACTION PALLIATIVE RADIOTHERAPY FOR SYMPTOMATIC HEPATOCELLULAR CARCINOMA AND LIVER METASTASES
2008
-
THE USE OF RADIATION THERAPY IN THE RADICAL TREATMENT OF RECTAL CANCER: A POPULATION BASED STUDY
2008
-
TWO-YEAR RESULTS OF THE CANADIAN FEASIBILITY STUDY OF ACCELERATED PARTIAL BREAST IRRADIATION (APBI) USING 3D CONFORMAL RADIATION THERAPY (3D-CRT)
2008
-
A low-dose ipsilateral lung constraint improves planning for partial breast irradiation
2007
-
A phase I study of concurrent pemetrexed Cisplatin radiation for unresectable stage IIIA/B non-small cell lung cancer
2007
-
A simple approach for quantitative imaging of fluorescent point sources in small animals
2007
-
Apoptotic cell death detection by high-frequency ultrasound spectroscopy; Monitoring of photodynamic therapy in vivo
2007
-
CT imaging in cervical cancer: Determination of dose delivered to bladder and rectum during intracavitary brachytherapy
2007
-
Can we standardize steroid dose in patients with brain metastases? A prospective study
2007
-
Credentialing of radiation oncologists' seroma contouring for the randomized trial of accelerated partial breast irradiation (RAPID)
2007
-
Difficulties associated with treatment optimization of high dose rate brachytherapy distributions for treatment of the endometrium with vaginal cylinders
2007
-
Dosimetric effects of immediate post-mastectomy breast reconstruction on chest wall radiotherapy
2007
-
Endoscopic-Guided Brachytherapy (EGB) for the palliation of advanced esophageal cancers
2007
-
Evidence to support improving cancer patient supportive care through community nursing: Results of a prospective study
2007
-
Feasibility testing of a quality assurance process for a cone-beam CT enabled online planning and treatment model for palliative radiotherapy
2007
-
High dose rate intraluminal Brachytherapy (HDRILBT) in lung cancer: A review of two years
2007
-
High frequency ultrasound Imaging of cell structural changes following radiation therapy
2007
-
Is body mass index a predictor for rectal dosimetry and toxicity in 125I permanent implant for low-risk prostate cancer?
2007
-
Long term urinary sequelae following iodine 125 prostate brachytherapy
2007
-
Ontario radiation oncology residents needs in the PGY-1 year - Residents' perspective survey
2007
-
Pain flare following radiotherapy for painful bone metastases: A joint effort of three cancer centres to determine the incidence
2007
-
Patterns of end of life cancer care: Health service use and predictors
2007
-
Plasma membrane and cytoplasmic activated EGF receptor predicts survival and cytoplasmic activated Erk predicts tumour response in locally advanced NSCLC patients treated with chemo-radiotherapy
2007
-
Preliminary evaluation of diffusion MRI to assess liver radiotherapy
2007
-
Relationships between PSA bounce and definitions of biochemical failure following I-125 brachytherapy for localized, low-risk prostate cancer
2007
-
Secondary malignancies among survivors of Hodgkin's lymphoma: An institutional review of the current screening practices for breast cancer following thoracic irradiation
2007
-
The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry
2007
-
The value of CT Imaging for treatment planning for brachytherapy in lung cancer
2007
-
Treatment of large fields for head and neck IMRT
2007
-
Using high-frequency spectroscopic ultrasound to monitor radiation and chemotherapy effects in lymphomas
2007
-
What is adequate radiotherapy quality assurance in phase III clinical trials involving radiation therapy?
2007
-
Worklife in Brachytherapy
2007
-
Assessment of intra-fraction motion for on-line planning and delivery of radiotherapy for patients with spinal metastases
2007
-
Human papilloma virus phv infection. Prevalence, clinical presentation and relevance of various protein markers in squamous cell carcinoma of head and neck (SCCHN)
2007
-
10 Acute phase response reactants as an objective measure of mucosal toxicity in head and neck cancer patients undergoing radical radiation therapy with or without concurrent chemo-therapy
2006
-
106 What is the impact of 4D CT on the planning of esophageal cancer?
2006
-
129 Inter-observer variability in gross tumour volume delineation in locally advanced non-small cell lung cancer cases: An institutional review
2006
-
162 Radiation dose to the internal pudendal arteries from iodine 125 prostate brachytherapy
2006
-
169 The impact of positron emission tomography (PET) in stage III non-small cell lung cancer: A prospective randomized clinical trial-improving clinical trials accrual using screening log evaluations
2006
-
183 Can an In Vitro Assay Predict Radiation Sensitivity in Patients with Carcinoma of the Prostate?
2006
-
202 Research and professional development: Video/phone Conference as a format for advancements in palliative radiotherapy
2006
-
226 Timing of androgen deprivation therapy after radical radiotherapy failure — A survey of Canadian practitioners
2006
-
28 Supportive care service needs of newly diagnosed cancer patients: Results of a population based study
2006
-
34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP)
2006
-
53 Initial results of a canadian feasibility study of accelerated partial breast irradiation (APBI) using 3-D conformal radiation therapy (3D CRT)
2006
-
63 Primary and adjuvant chemoradiotherapy for locally advanced pancreatic cancer: A phase I/II study with long term outcome
2006
-
69 The impact of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) on radiotherapy planning in carcinoma of the esophagus
2006
-
121 The use of bisphosphonates in men with hormone-refractory prostate cancer: A systematic review of randomized trials
2005
-
138 Inflammatory serum markers as an objective measure of radiation mucositis in head and neck cancer
2005
-
14 Randomized Trial Comparing Iridium Plus External-Beam Radiation Therapy with External-Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate
2005
-
201 Anatomical variables may determine the value of IMRT in intermediate risk prostate cancer: A dosimetric evaluation between IMRT and 3D-CRT PLANS
2005
-
202 Relationship of the International Prostate Symptom Score with urinary flow studies, and catherization rates following iodine 125 prostate brachytherapy
2005
-
212 Resection of radiosurgically treated recurrent brain metastases: Pathological findings and subsequent survival
2005
-
58 Radiation target volume delineation (TVD) using FDG-PET and contrast enhanced CT (CECT) for patients with head and neck cancer
2005
-
73 A prospective study to evaluate the need for an immobilization device for treating modified mantle fields in lymphoma patients
2005
-
95 Stereotactic program development in the management of meningioma
2005
-
Evaluation of inflammatory serum proteins as an objective measure of radiation induced mucositis in patients receiving radical radiation with or without concurrent chemotherapy
2004
-
A study examining epidermal growth factor receptor, p53, and Bcl-2 expression in patients with stage III and IV squamous cell carcinoma of the head and neck treated with concomitant chemo-radiotherapy.
2004
-
Anatomical variables may determine the value of IMRT in intermediate risk prostate cancer: A dosimetric evaluation between IMRT and 3D-CRT plans.
2004
-
Anatomical variables may determine the value of IMRT in intermediate risk prostate cancer: A dosimetric evaluation between IMRT and 3D-Crt plans
2004
-
Clinical screening for lymphedema in breast cancer patients: Validation of Canadian guidelines.
2004
-
Computerized tomographic simulation compared to clinical mark-up in palliative radiotherapy: A prospective study
2004
-
Correlation between two surrogate outcomes: Post-radiotherapy biopsy (PRB) and PSA failure (BCF): Results from a randomized hypofractionated study in localized prostate cancer
2004
-
How can we use genomics to understand non-targeted effects of radiotherapy?
2004
-
Lymphedema in breast cancer patients screened during the first year of a randomized trial: Is treatment always the cause?
2004
-
Malignant thymoma: A review of treatment experience from two Canadian institutions.
2004
-
Mitogen-activated protein kinase (MAPK) expression and activation in non-small cell lung cancer (NSCLC): Investigating their prognostic significance and role in radiation responses.
2004
-
Penile brachytherapy: Results for 49 patients
2004
-
Pre-treatment assessment of repositioning accuracy of patients immobilized using the VBH HeadFIX system.
2004
-
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Does dose escalation improve local recurrence free survival and disease free survival?
2004
-
Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone
2004
-
Results of a randomised trial of follow-up strategies for breast cancer: Family physician versus cancer centre care
2004
-
The use and toxicity of steroids in the management of patients with brain metastases.
2004
-
Thyroid function screening following radiation therapy for cancers of the head and neck: A survey of Canadian practice patterns
2004
-
Virtual wedge and intensity modulated radiotherapy reduce the magnitude of scattered radiation during adjuvant breast radiation.
2004
-
Which radiation regimen should be used for Bowen's disease of the skin?
2004
-
Brachytherapy for penile cancer: results for 49 patients
2004
-
Real-time remote education and knowledge exchange in medical physics using the internet
2003
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)